Thursday, May 24, 2012 Last update: 9:05 AM
U.S. Technology Company News from the Inside
MabCure, Inc.
News articles for MabCure, Inc.:
Thursday, December 15, 2011
- MabCure, Inc. Announces Completion of Its Ovarian Cancer Diagnostic Study in ThailandMabCure, Inc. (OTCBB:MBCI), a leading developer of antibody based diagnostics and treatments for ovarian, prostate and other cancers today announced that it has recently completed its prospective diagnostic ... read more